Published March 23, 2022 | Version v1
Journal article

Development of 2-deoxystreptamine–nucleobase conjugates for the inhibition of oncogenic miRNA production

Description

2-deoxystreptamine (2-DOS) conjugates with artificial nucleobases were designed and synthesized to inhibit pre-miR-372 processing into oncogenic miRNA and were discovered to be promising inhibitors when compared to their neomycin counterpart.

Abstract

International audience

Additional details

Created:
December 4, 2022
Modified:
November 30, 2023